134 related articles for article (PubMed ID: 26547594)
1. Role of pharmacist-provided point of care testing.
Kuhn CH
J Am Pharm Assoc (2003); 2015; 55(6):572-573. PubMed ID: 26547594
[No Abstract] [Full Text] [Related]
2. Community pharmacy-based point-of-care testing: A case study of pharmacist-physician collaborative working relationships.
Bacci JL; Klepser D; Tilley H; Smith JK; Klepser ME
Res Social Adm Pharm; 2018 Jan; 14(1):112-115. PubMed ID: 28082033
[TBL] [Abstract][Full Text] [Related]
3. Recognition of community-based pharmacist practitioners: Essential health care providers.
Bennett M; Goode JV
J Am Pharm Assoc (2003); 2016; 56(5):580-3. PubMed ID: 27594108
[TBL] [Abstract][Full Text] [Related]
4. Point-of-Care Testing in Community Pharmacies: Keys to Success From Pennsylvania Pharmacists.
Steltenpohl EA; Barry BK; Coley KC; McGivney MS; Olenak JL; Berenbrok LA
J Pharm Pract; 2018 Dec; 31(6):629-635. PubMed ID: 29034781
[TBL] [Abstract][Full Text] [Related]
5. The I-Tribe Community Pharmacy Practice Model: professional pharmacy unshackled.
Alston GL; Waitzman JA
J Am Pharm Assoc (2003); 2013; 53(2):163-71. PubMed ID: 23571624
[TBL] [Abstract][Full Text] [Related]
6. Assessing pharmacist-led annual wellness visits: Interventions made and patient and physician satisfaction.
Wilson CG; Park I; Sutherland SE; Ray L
J Am Pharm Assoc (2003); 2015; 55(4):449-54. PubMed ID: 26161489
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist participation in health policy development.
Matzke GR
Am J Health Syst Pharm; 2016 Feb; 73(3):107. PubMed ID: 26796902
[No Abstract] [Full Text] [Related]
8. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.
Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D
Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770
[TBL] [Abstract][Full Text] [Related]
9. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
[TBL] [Abstract][Full Text] [Related]
10. Informal learning processes in support of clinical service delivery in a service-oriented community pharmacy.
Patterson BJ; Bakken BK; Doucette WR; Urmie JM; McDonough RP
Res Social Adm Pharm; 2017; 13(1):224-232. PubMed ID: 26935794
[TBL] [Abstract][Full Text] [Related]
11. Establishing pathways for access to pharmacist-provided patient care.
Schommer JC; Doucette WR; Planas LG
J Am Pharm Assoc (2003); 2015; 55(6):664-668. PubMed ID: 26547600
[TBL] [Abstract][Full Text] [Related]
12. On the frontline against COVID-19: Community pharmacists' contribution during a public health crisis.
Cadogan CA; Hughes CM
Res Social Adm Pharm; 2021 Jan; 17(1):2032-2035. PubMed ID: 32245691
[TBL] [Abstract][Full Text] [Related]
13. Community pharmacist management of discharge medication summaries in primary care.
Wilcock M; Bearman D
Drug Ther Bull; 2019 Dec; 57(12):179-180. PubMed ID: 31527148
[No Abstract] [Full Text] [Related]
14. Community pharmacists and communication in the time of COVID-19: Applying the health belief model.
Carico RR; Sheppard J; Thomas CB
Res Social Adm Pharm; 2021 Jan; 17(1):1984-1987. PubMed ID: 32247680
[TBL] [Abstract][Full Text] [Related]
15. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0).
;
J Am Pharm Assoc (2003); 2008; 48(3):341-53. PubMed ID: 18595820
[TBL] [Abstract][Full Text] [Related]
16. The pharmacist as educator and storyteller.
Ponte CD
Diabetes Educ; 2002; 28(5):682-5. PubMed ID: 14625955
[No Abstract] [Full Text] [Related]
17. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
18. Restructuring the role of the community pharmacists.
White EV; Latif DA
J Am Pharm Assoc (2003); 2006; 46(5):532, 535. PubMed ID: 17036638
[No Abstract] [Full Text] [Related]
19. Exploring the General Practitioner-pharmacist relationship in the community setting in Ireland.
Moore T; Kennedy J; McCarthy S
Int J Pharm Pract; 2014 Oct; 22(5):327-34. PubMed ID: 24433551
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a pharmacogenomics service in a community pharmacy.
Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
